| Aberrant signaling pathways in glioma M Nakada, D Kita, T Watanabe, Y Hayashi, L Teng, IV Pyko, JI Hamada Cancers 3 (3), 3242-3278, 2011 | 335 | 2011 |
| Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy L Teng, M Nakada, SG Zhao, Y Endo, N Furuyama, E Nambu, IV Pyko, ... British journal of cancer 104 (5), 798-807, 2011 | 190 | 2011 |
| Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy T Domoto, IV Pyko, T Furuta, K Miyashita, M Uehara, T Shimasaki, ... Cancer science 107 (10), 1363-1372, 2016 | 180 | 2016 |
| Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O 6 -methylguanine DNA methyltransferase … IV Pyko, M Nakada, H Sabit, L Teng, N Furuyama, Y Hayashi, ... Carcinogenesis 34 (10), 2206-2217, 2013 | 79 | 2013 |
| Receptor tyrosine kinases: principles and functions in glioma invasion M Nakada, D Kita, L Teng, IV Pyko, T Watanabe, Y Hayashi, J Hamada Glioma Signaling, 151-178, 2020 | 74 | 2020 |
| Expression of fatty acid‐binding proteins in adult hippocampal neurogenic niche of postischemic monkeys NB Boneva, DB Kaplamadzhiev, S Sahara, H Kikuchi, IV Pyko, M Kikuchi, ... Hippocampus 21 (2), 162-171, 2011 | 55 | 2011 |
| Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway Y Chikano, T Domoto, T Furuta, H Sabit, A Kitano-Tamura, IV Pyko, ... Molecular cancer therapeutics 14 (2), 564-574, 2015 | 53 | 2015 |
| Bone marrow-derived stromal cells can express neuronal markers by DHA/GPR40 signaling. DB Kaplamadzhiev, H Hisha, Y Adachi, S Ikehara, AB Tonchev, ... BioScience Trends 4 (3), 2010 | 32 | 2010 |
| The pivotal roles of GSK3β in glioma biology M Nakada, T Minamoto, IV Pyko, Y Hayashi, J Hamada Molecular targets of CNS tumors, 2011 | 23 | 2011 |
| Aberrant signaling pathways in glioma. Cancers (Basel). 2011; 3: 3242–3278 M Nakada, D Kita, T Watanabe, Y Hayashi, L Teng, IV Pyko | 2 | |
| Research into protective efficacy of transplantation of cultured bone marrow mesenchymal stem cells in mice for focal traumatic brain injury treatment: P1736 IV Pyko, AS Fedulov, ZB Kvacheva European Journal of Neurology 15, 216, 2008 | 1 | 2008 |
| Investigation of putative roles for GSK3b in glioblastoma stemness phenotype and the underlying biological mechanisms I Pyko 令和 1 (2019) 年度 科学研究費補助金 若手研究 研究概要 2018, 2p., 2021 | | 2021 |
| Clinical features of pituitary adenomas with apoplexy in emergency situations I Pyko, Y Hayashi, Y Sasagawa, D Kita, I Fukui, M Oishi, M Nakada Neurosurgical emergency 24 (1), 28-31, 2019 | | 2019 |
| Glycogen synthase kinase (GSK) 3 beta induces protooncogenic autophagy in colon cancer T Domoto, IV Pyko, D Bolidong, M Uehara, T Minamoto CANCER SCIENCE 109, 250-250, 2018 | | 2018 |
| Implication of GPR40 Signaling in the Subventricular Zone Neurogenesis after Ischemia via Cross-Talk between Neural Progenitors and Microglia MY Dazortsava, IV Pyko, NB Boneva, AB Tonchev, H Zhu, K Sawamoto, ... J Alzheimers Dis Parkinsonism 8 (6), 454, 2018 | | 2018 |
| Investigation of the therapeutic interaction of mesenchymal stem cells with glioblastoma stem-like cells and its biological mechanism ピコイリア 平成 29 (2017) 年度 科学研究費補助金 若手研究 (B) 研究成果報告書 2016, 4p., 2018 | | 2018 |
| Putative role of glycogen synthase kinase (GSK)-3 beta in acquired resistance to gemcitabine (GEM) in pancreatic cancer M Uehara, T Domoto, S Takenaka, P Ilya, T Shimasaki, T Miyashita, ... CANCER SCIENCE 109, 708-708, 2018 | | 2018 |
| Sensitizing patient-derived glioblastoma stem-like cells to temozolomide by glycogen synthase kinase 3 beta inhibition IV Pyko, T Domoto, M Nakada, T Minamoto CANCER SCIENCE 109, 922-922, 2018 | | 2018 |
| Aberrant glycogen synthase kinase (GSK) 3 beta participates in proliferation of esophageal squamous cell carcinoma (ESCC) D Bolidong, T Domoto, T Okumura, Y Endo, M Uehara, IV Pyko, ... CANCER SCIENCE 109, 698-698, 2018 | | 2018 |
| Development of combined cellular and molecular target-directed therapies for glioblastoma ピコイリア 平成 27 (2015) 年度 科学研究費補助金 研究活動スタート支援 研究成果報告書 2014, 4p., 2016 | | 2016 |
